The Latest in Conference Coverage

WCD: Psoriasis plus depression magnifies MI risk

June 16, 2015

Psoriasis

EULAR: Epigenetics points to anti-TNF efficacy in psoriatic arthritis

June 12, 2015

Psoriasis

VIDEO: Predicting anti-TNF failure in psoriatic arthritis

June 12, 2015

Psoriasis

WCD: Ustekinumab succeeds as switch agent in psoriasis

June 11, 2015

Psoriasis

WCD: Tofacitinib’s benefits for psoriasis persist for 2 years

June 11, 2015

Psoriasis

Anti-TNFs help psoriatic arthritis patients get back to work

June 11, 2015

Psoriasis

BSR: Multiple benefits seen with intensive psoriatic arthritis therapy

May 22, 2015

Psoriasis

Apremilast meets psoriasis endpoints at week 32

April 12, 2015

Psoriasis

Ixekizumab met psoriasis endpoints by week 12, with durable response at 60 weeks

April 9, 2015

Psoriasis

Secukinumab beat ustekinumab for psoriasis, with difference by week four

March 21, 2015

Psoriasis

Brodalumab achieved primary endpoints for moderate to severe psoriasis at 52 weeks

March 21, 2015

Psoriasis

New psoriasis drugs offer treatment advantages

February 27, 2015

Psoriasis

Data suggest link between tonsillectomy, psoriasis improvement

February 25, 2015

Psoriasis

Survey: Psoriasis/psoriatic arthritis undertreated

January 30, 2015

Psoriasis

Ixekizumab linked to decrease in psoriasis-related sexual difficulties

December 14, 2014

Psoriasis